Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components

Vox Sanguinis

Volumn 77, Issue 2, 1999, Pages 88-96

  MacGregor, Ian ^a   Hope, James ^c   Barnard, Geoff ^c   Kirby, Louise ^c   Drummond, Olive ^a   Pepper, Duncan ^a   Hornsey, Valerie ^a   Barclay, Robin ^a   Bessos, Hagop ^a   Turner, Marc ^a,b   Prowse, Christopher ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CELL; CELLULAR DISTRIBUTION; ERYTHROCYTE; FLUOROIMMUNOASSAY; HUMAN; HUMAN TISSUE; LEUKOCYTE; NEUTROPHIL; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE;

ANTIGENS; BLOOD PLATELETS; DRUG STABILITY; ERYTHROCYTES; FLUOROIMMUNOASSAY; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; PLASMA; PRIONS;

EID: 0032861112     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031082     Document Type: Article

References (36)

1. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
2. Ironside JW: Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Microbiol 1998;21:91-95.
3. Bruce ME, Will RG, Ironside JW, Mcconnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
4. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-690.
5. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J, Doey LJ, Lantos P: The same prion strain causes vCJD and BSE. Nature 1997;389:448-450.
6. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM, Aguzzi A: A crucial role for B cells in neuroinvasive scrapie. Nature 1997; 390:687-690.
7. Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, Zinkernagel RM, Weissmann C, Aguzzi A: PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 1998;4:1429-1433.
8. Mabbott NA, Farquhar CF, Brown KL, Bruce ME: Involvement of the immune system in TSE pathogenesis. Immunol Today 1998;19: 201-203.
9. Turner ML, Ironside JW: New-variant Creutzfeldt-Jakob disease: The risk of transmission by blood transfusion. Blood Rev 1998;12: 255-268.
10. Cousens SN, Zeidler M, Esmonde TF, DeSilva R, Wilesmith JW, Smith PG, Will RG: Sporadic Creutzfeldt-Jakob disease in the United Kingdom: Analysis of epidemiological surveillance data for 1970-96. Br Med J 1997; 315:389-395.
11. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J: Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703-704.
12. Hill AF, Zeidler M, Ironside J, Collinge J: Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
13. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J: Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-189.
14. UK Department of Health: Press Release 98/295. Government accepts advice on leucodepletion from Spongiform Encephalopathy Advisory Committee. 17th July 1998. Press Release 1998;98/295.
15. UK Department of Health: Press Release 98/076. Further precautionary measures on blood products announced. 26th February 1998. Press Release 1998;98/076.
16. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T: Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32-40.
17. Otto M, Wiltfang J, Schutz E, Zerr I, Otto A, Pfahlberg A, Gefeller O, Uhr M, Giese A, Weber T, Kretzschmar HA, Poser S: Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control. BMJ 1998;316:577-582.
18. Aguzzi A, Weissmann C: Prion research: The next frontiers. Nature 1997;389:795-798.
19. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE: Prion protein biology. Cell 1998;93:337-348.
20. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H: Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Viral 1987;61:3688-3693.
21. Schmerr MJ, Jenny A: A diagnostic test for scrapie-infected sheep using a capillary electrophoresis immunoassay with fluorescent-labeled peptides. Electrophoresis 1998;19:409-414.
22. Safar J, Wille H, Itrri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB: Eight prion strains have PrPSc molecules with different conformations. Nat Med 1998;4:1157-1165.
23. Hemmila I: Lanthanides as probes for time-resolved fluorometric immunoassays. Scand J Clin Lab Invest 1988;48:389-399.
24. Diomede L, Sozzani S, Luini W, Algeri M, De Gioia L, Chiesa R, Lievens PM, Bugiani O, Forloni G, Tagliavini F, Salmona M: Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. Biochem J 1996;320:563-570.
25. George JN: Platelet immunoglobulin G: Its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood 1990;76:859-870.
26. Kascsak RJ, Tonna-DiMasi M, Fersko R, Rubenstein R, Carp RI, Powers JM: The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies; in Brown F (ed): Transmissible Spongiform Encephalopathies - Impact on Animal and Human Health. Basel, Karger, 1993, pp 141-151.
27. Farquhar CF, Dornan J, Moore RC, Somerville RA, Tunstall AM, Hope J: Protease-resistant PrP deposition in brain and non-central nervous system tissues of a murine model of bovine spongiform encephalopathy. J Gen Virol 1996;77:1941-1946.
28. Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE: Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990;61:185-192.
29. Perini F, Frangione B, Prelli F: Prion protein released by platelets. Lancet 1996;347:1635-1636.
30. Perini F, Vidal R, Ghetti B, Tagliavini F, Frangione B, Prelli F: PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun 1996;223:572-577.
31. Dodelet VC, Cashman NR: Prion protein expression in human leukocyte differentiation. Blood 1998;91:1556-1561.
32. Holada K, Mondoro TK, Muller J, Vostal JG: Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets. Br J Haematol 1998;103:276-282.
33. Civenni G, Test ST, Brodbeck U, Butikofer P: In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane. Blood 1998;91:1784-1792.
34. Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M: Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost 1994;72:666-671.
35. Lehmann S, Daude N, Harris DA: A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells. Mol Brain Res 1997;52:139-145.
36. Harrison P, Cramer EM: Platelet alpha-granules. Blood Rev 1993;7:52-62.